Joshua Salomon @jsalomon.bsky.social
@salomonja
Probabilistic optimist | Infectious disease, decision science, policy modeling, public health, global health | Prof @StanfordMed | Dir ppml.stanford.edu
ID: 269346138
http://profiles.stanford.edu/joshua-salomon 20-03-2011 15:54:39
1,1K Tweet
3,3K Followers
1,1K Following
.Matthew Herper on why we’re not ready to capitalize on “biology’s century.” In part, it’s our belief that inventing new gadgets is the answer to everything. “[W]e try to solve problems by building faster and more expensive Ferraris when what we really need are better roads.”
.Shiying estimated QALYs lost associated with genital herpes infection (HSV-1, HSV-2) in the US providing burden estimates for adults and neonates. Published in The Lancet Reg Health-Americas. Co-authors: Reza Yaesoubi Yunfei Li Kyu Lee Joshua Salomon @jsalomon.bsky.social Minttu Rönn 🌻 sciencedirect.com/science/articl…
.Claire Cain Miller Sarah Kliff Larry Buchanan of The New York Times were amazing and committed to getting every single detail of the data right, which resulted in this careful and thoughtful article about our paper. Thank you! nytimes.com/interactive/20…
Check out the new work out: Yunfei Li estimated QALYs lost associated with chlamydia, gonorrhea and trichomoniasis infections in the United States. Co-authors include Shiying, Kyu Lee, Reza Yaesoubi, Joshua Salomon @jsalomon.bsky.social, Minttu Rönn 🌻 academic.oup.com/jid/advance-ar…
New preprint out which examines how to deploy a new antibiotic for #gonorrhea in a way that maximizes its clinically useful lifespan. Work led by Emily Reichert and Yonatan Grad. Co-authors include Reza Yaesoubi Joshua Salomon @jsalomon.bsky.social Minttu Rönn 🌻 medrxiv.org/content/10.110…
New work from the team analyzing cost-effectiveness of chlamydia screening and partner notification in the United States during 2000–2019. Authors: Minttu Rönn 🌻 Yunfei Li Nick Menzies Joshua Salomon @jsalomon.bsky.social journals.lww.com/stdjournal/Abs…
“Today’s approval of OTC naloxone nasal spray will help improve access […and] reduce opioid overdose deaths throughout the country. We encourage the manufacturer to make accessibility to the product a priority …” Dr. Robert M. Califf nytimes.com/2023/03/29/hea…
Researchers collaborate w/CDC on new HepB screening recommendation. "The new hepatitis B screening guidance supplies a good example of the value of this type of partnership for co-developing essential evidence for policy," says SHP's Joshua Salomon @jsalomon.bsky.social. Read: stan.md/40UaDYE
My first, first-author paper is out in Medical Decision Making!!! I'm very thankful to my co-authors and mentors, Jane Tan, Glenn Chertow, and Jeremy Goldhaber-Fiebert, for helping to make this happen journals.sagepub.com/doi/10.1177/02… (full text will be on PubMed soon)
Congrats to Sherri Rose for earning the 2023 President’s Award for Excellence Through Diversity Stanford University. Sherri is a tireless advocate for justice, equity and inclusion, and she inspires and challenges us all to aim higher and work harder against an unacceptable status quo.
PPML at StanfordHealthPolicy is recruiting for postdocs to conduct analyses and modeling relating to the health impact, costs, and cost-effectiveness of infectious disease prevention and treatment strategies. Opportunity to drive impactful research with Joshua Salomon @jsalomon.bsky.social! postdocs.stanford.edu/prospective/op…
In their new Forefront article, Robert Kaplan, Joshua Salomon @jsalomon.bsky.social, Peter Neumann + Marthe Gold from Stanford University Tufts University + The New York Academy of Medicine discuss how House-passed legislation would ban the use of QALYs, a metric to enable wise use of limited health care resources. bit.ly/3JJwI5a
In Health Affairs Forefront today, Bob Kaplan, Joshua Salomon @jsalomon.bsky.social, Marthe Gold & I argue that QALYs or related methods are the best way to assure fair treatment of people with disabilities & chronic illnesses. tinyurl.com/2p94uduc CEVR ICER UW School of Pharmacy Stacie Dusetzina